Images
![Rivastigmine (Rivastigmine (oral) [ ri-va-stig-meen ])-SANDOZ 619-3 mg-Orange-Capsule-shape](https://cdn.themeditary.com/vimedia/h200/2023/08/13/rivastigmine-rivastigmine-oral-ri-va-stig-meen-sandoz-619-3-mg-orange-capsule-shape-54577472-15213.webp "SANDOZ 619 Pill - orange capsule-shape, 18mm")
![Rivastigmine (Rivastigmine (oral) [ ri-va-stig-meen ])-SANDOZ 619-3 mg-Orange-Capsule-shape](https://cdn.themeditary.com/vimedia/h200/2023/08/13/rivastigmine-rivastigmine-oral-ri-va-stig-meen-sandoz-619-3-mg-orange-capsule-shape-54577472-15214.webp "SANDOZ 619 Pill - orange capsule-shape, 18mm")
![Rivastigmine (Rivastigmine (oral) [ ri-va-stig-meen ])-SANDOZ 619-3 mg-Orange-Capsule-shape](https://cdn.themeditary.com/vimedia/h200/2023/08/13/rivastigmine-rivastigmine-oral-ri-va-stig-meen-sandoz-619-3-mg-orange-capsule-shape-54577472-15215.webp "SANDOZ 619 Pill - orange capsule-shape, 18mm")
Rivastigmine |
|
| Generic Name: | rivastigmine (oral) [ ri-va-stig-meen ] |
| Imprint: | SANDOZ 619 |
| Strength: | 3 mg |
| Color: | Orange |
| Size: | 18.00 mm |
| Shape: | Capsule-shape |
| Availability: | Prescription only |
| Drug Class: | Cholinesterase inhibitors |
| Pregnancy Category: | B - No proven risk in humans |
| CSA Schedule: | Not a controlled drug |
| Labeler / Supplier: | N/A |
| National Drug Code (NDC): | 00781-2615 (Discontinued) |
| Inactive Ingredients: | Gelatin, Hypromelloses, Magnesium stearate, Microcrystalline cellulose, Ferric oxide red, Silicon dioxide, Titanium dioxide, Ferric oxide yellow, |
